Wuhan General Group acquires
MJ MedTech
Montreal, QC --
January 22, 2019 -- InvestorsHub NewsWire -- Wuhan
General Group (China), Inc. (OTC
PINK: WUHN) (the "Company" and
"Wuhan"), announces today that the Company has successfully
completed the acquisition of MJ MedTech,
a nutraceutical
biotechnology company that owns, develops and commercializes
a range of
CBD-based products under the International trademarked brand
Dr. AnnaRx.
With the closing
of the acquisition, Jeff Robinson will continue in his role as CEO
and President of MJ MedTech, and will be joining the Board of
Directors of Wuhan. Also, Dr. Anna
Leralta
will be appointed
Secretary and Treasurer of Wuhan, and will be joining the Board of
Directors of Wuhan as well. The reorganization will take place in
the coming days as we go through the transition.
"I'm very pleased
and excited to have completed the MJ MedTech
acquisition, as it represents a significant opportunity to take
part in the ever-expanding cannabis sector. At the center of this
decision was the value creation we promised to our investors and
shareholders, as well as the sustainable success of the Wuhan
General Group as a company." said CEO Mr. Kamaneh. "I look forward
to integrating both Jeff and Anna into the leadership team of
Wuhan."
''Dr. Anna and I
are both very eager to begin executing and delivering for Wuhan
shareholders. We look forward to
sharing our 2019 roadmap and milestones in the very near future."
said Jeff Robinson.
About Wuhan General Group (China), Inc.
Wuhan General
Group (China), Inc. through its wholly owned subsidiary
MJ MedTech is a
nutraceutical biotechnology company that
owns, develops and commercializes a range of CBD-based products. At
Wuhan, our mission is to advance CBD-based medicine to the
forefront by deploying best practice science and medicine, clinical
research and emerging technologies.
For further information
contact:
Publicly
traded company (OTC Pink:
WUHN)
Website: www.wuhn.org
Public Relations
E-mail: info@wuhn.org
Forward-Looking Statements:
Safe Harbour
Statement - In addition to historical information, this press
release may contain statements that constitute forward-looking
statements within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements contained in this press release include
the intent, belief, or expectations of the Company and members of
its management team with respect to the Company's future business
operations and the assumptions upon which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future
performance, and involve risks and uncertainties and
that
actual results may differ materially from those contemplated by
such forward-looking statements. Factors that could cause these
differences include, but are not limited to, failure to complete
anticipated sales under negotiations, lack of revenue
growth,
client discontinuances, failure to realize improvements in
performance, efficiency and profitability, and adverse developments
with respect to litigation or increased litigation costs, the
operation or performance of the Company's business units or
the market
price of its common stock. Additional factors that could cause
actual results to differ materially from those contemplated within
this press release can also be found on the Company's website. The
Company disclaims any responsibility to update any
forward-looking
statements.
Source: Wuhan
General Group (China), Inc.